Effect of magnesium sulphate on prolonging the duration of analgesia in inguinal hernia surgeries
Not Applicable
Completed
- Conditions
- Health Condition 1: null- INGUINAL HERNIA
- Registration Number
- CTRI/2018/01/011509
- Lead Sponsor
- JERRY JAME JOY
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 80
Inclusion Criteria
ASA I & II
Exclusion Criteria
Patient refusal for the procedure
ASA III & IV.
Age <18 & >55 years.
Contraindication to spinal anaesthesia.
History of allergy to test drugs.
Patients with altered Magnesium levels.
Prior intake/supplementation of Magnesium for any reason
Preoperative analgesic administration
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.Duration of AnalgesiaTimepoint: 1.Time from intrathecal administration of drug to the time when patient complaints of pain at the surgical site or VAS score reaches greater than four
- Secondary Outcome Measures
Name Time Method 1.onset of sensory blockade <br/ ><br>2.Onset of motor blockade <br/ ><br>3. Duration of sensory blockade <br/ ><br>4. Duration of motor blockadeTimepoint: 1.Onset of sensory blockade: Time interval from subarachnoid injection to loss of pinprick sensation at T10 level. <br/ ><br>2.Onset of motor blockade: time to attain modified Bromage scale 3 <br/ ><br>3.Duration of sensory blockade:time interval from highest sensory level to complete recovery of sensory blockade. <br/ ><br>4.Duration of motor blockade: time to regain Modified Bromage Grade 1.